drugset / Trial / NCT05109104

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products

NCT05109104

Completed 13 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

Timeline

Start
2021-11-08
Primary completion
2021-12-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CAP Herbal Mint Unknown 80 mg Topical
Subject CAP Mountain Berry Unknown 80 mg Topical
Subject CAP UnScented Unknown 80 mg Topical
Comparator Oxybenzone Small molecule 3 %
Comparator Padimate-O Small molecule 7 %

Indications

No indication recorded.